A manufacturer-funded study found a significant decrease in annual total medical costs in patients with overweight/obesity ...

More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug ...

Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...

Ministers have been urged to ditch "gimmicks and soundbites" while addressing the soaring cost of obesity to the NHS.

As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.

The FDA’s decision to allow the compounding of GLP-1 weight loss drugs could undermine its public health obligations, writes ...

It sounds great, considering the cost of brand-name drugs ... of new form of mpox in a traveler You will likely see ...

The use of diabetes and weight-loss medications like Ozempic or Wegovy—called GLP-1 drugs—has exploded in recent years, with ...

Diabetes and weight-loss drug tirzepatide (Mounjaro, Zepbound) was listed as a contributing factor in the death of a 58-year-old nurse from Scotland who died of multiple organ failure, septic shock, ...

More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...